Day 1 - Tuesday, November 18, 2025Tuesday, 18 November 2025 - ET (Eastern Time, GMT-05:00)

Before diving into deeper, supplemental sessions, take this opportunity for a broader level set. Gain insight into current policies and pending changes to understand how the copay industry will be affected in 2025, and beyond, and learn the steps that your organization should be taking to prepare and adapt accordingly.

With increasing cost pressures and evolving payer strategies, manufacturers must continually adapt their copay programs. This session provides insights into innovative program structures, split adjudication, specialty pharmacy coordination and compliance best practices to ensure long-term program success.

In this session, attendees gain a comprehensive understanding of how analyzing copay data can reveal critical patterns and trends that impact patient behavior and treatment adherence. Learn about practical examples and case studies demonstrating how leveraging these insights can lead to more personalized patient experiences, ultimately enhancing satisfaction and adherence to prescribed treatments. Key takeaways include:

• Understanding the role of copay data in identifying barriers to treatment adherence

• Strategies for utilizing copay insights to design patient-centric interventions

• Real-world examples of improved patient outcomes through data-driven approaches

• Best practices for integrating copay data analysis into existing healthcare frameworks

Gain key insights on enforcement trends and upcoming areas of focus for 2025 and beyond, specifically looking at guidance on field-based roles, prior authorization and carveout watch-outs.

Alongside patient trends, copay program data can also provide valuable insights into payer dynamics, formulary positioning and patient affordability trends. This session explores how manufacturers can effectively collect, analyze and utilize data to refine their market access strategies and enhance their copay programs.

With reimbursement spend under scrutiny and pricing pressures intensifying, manufacturers must rethink their GTN strategy to balance profitability and patient access with long-term program sustainability.

• Discover tactical approaches to mitigate spend while maintaining patient affordability

• Benchmark best practices for contract negotiation

• Run through commercial vs. cash-paying GTN considerations

• Learn the different components that make up GTN such as, rebates, PBM fees, 340B pricing and accumulators, and their role in shaping net revenue

As your team gears up for an exciting product launch, it is essential that you have the right structure in place to ensure program success. Run through the timeline leading up to launch to guarantee that you have the right answers to all the following questions –

• How do you create a comprehensive launch, in which all internal stakeholders are educated and aligned?

• What are the key metrics to identify, and key conversations that should be had at, 18 months, 12 months, 6 months out, etc.?

• How do you determine if your current copay amount is sufficient for a new indication? If you were to change the amount, what are the organizational implications?

• How do you identify opportunities and gaps within your program to optimize patient outcome?

Once your copay program has been implemented, teams must remain agile to ensure that the program remains a seamless extension of the organization. Run through the timeline post launch to guarantee that you have the right answers to all the following questions –

• How do you make patient processes more effective?

• What does the bifurcation process look like from an operational perspective?

• What are best practices in collaborating with your specialty pharmacy, vendor partner and other external stakeholders?

• What are common barriers that manufacturers should expect throughout the program lifecycle?